GRASLND and melanoma: Since we found that GRASLND downregulation induces melanoma phenotype switching, which is associated with melanoma progression (Alonso et al., 2007; Li et al., 2015) and therapy resistance (Konieczkowski et al., 2014; Müller et al., 2014; Mehta et al., 2018; Lee et al., 2020), we were interested in its potential clinical relevance.